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Abstract
Background: Diarrhoea caused by Escherichia coli is an important cause of infant morbidity and
mortality in developing countries. Enteropathogenic Escherichia coli (EPEC) is considered one of the
major causes of diarrhoea in children living in developing countries. The ability of diarrhoeagenic
strains of E. coli to adhere to and colonize the intestine is the first step towards developing the
disease. EPEC strains adhere to enterocytes and HeLa cells in a characteristic pattern known as
localized adherence.
Many epidemiological studies of diarrhoea have shown that breast-feeding protects infants from
intestinal infections. Both immunoglobulin and non-immunoglobulin elements of human milk are
thought to contribute to the protection from diarrhoeal agents.
Results: The effects of human milk and its protein components on the localized adherence of EPEC
were investigated. Non-immunoglobulin components of human milk responsible for the inhibition
of EPEC adhesion to HeLa cells were isolated by chromatographic fractionation of human whey
proteins. Besides secretory immunoglobulin A, which has been previously reported to affect the
adhesion of EPEC, free secretory component (fSC) and lactoferrin (Lf) were isolated. Even in
concentrations lower than those usually found in whole milk, fSC and Lf were able to inhibit the
adhesion of EPEC. α -lactalbumin was also isolated, but showed no activity on EPEC adhesion.
Conclusions: This study demonstrated that the immunoglobulin fraction, the free secretory
component and lactoferrin of human milk inhibit EPEC adhesion to HeLa cells. These results
indicate that fSC and Lf may be important non-specific defence factors against EPEC infections.
Background
Enteropathogenic Escherichia coli (EPEC) strains com-
prise one of the various categories of diarrhoeagenic E.
coli and are the leading aetiological agent of infant acute
diarrhoea in Brazil [1,2]. Infection by EPEC involves ini-
tial adherence of the bacteria to the intestinal epithelial
cells via bundle-forming pilus (BFP), and subsequent inti-
mate contact mediated by an outer membrane protein, in-
timin. This process leads to the effacement of enterocyte
microvilli, forming what is known as the attaching and ef-
facing lesion [3,4]. EPEC strains adhere to HeLa and Hep
2 tissue culture cell lines, forming a kind of microcolony in
a pattern termed localized adherence; they also form sim-
ilar attaching and effacing lesion on cells in vitro [5].
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Many epidemiological studies of diarrhoea have shown
that breast-feeding protects infants from intestinal and
respiratory infections [6–8]. Both immunoglobulin and
non-immunoglobulin elements of human milk are
thought to contribute to protection against diarrhoeal
agents [9–14]. It has been demonstrated that human co-
lostrum, milk and oligosaccharides inhibited the local-
ized adherence of EPEC strains to cultured cells [9,15].
Furthermore, it has been shown that human colostrum
contains IgA that recognise BFP and intimin, the adher-
ence-associated proteins of EPEC [16,17]. These findings
indicate that interactions between milk elements and
bacteria do occur, preventing the attachment of bacteria
to epithelial cells [9,15–17].
In previous work, we have shown that the non-immu-
noglobulin fraction of human milk inhibits the adher-
ence of three other categories of diarrhoeagenic E. coli:
enterotoxigenic E. coli (ETEC), diffuse adhering E. coli
(DAEC), and enteroaggregative E. coli (EAEC) [18,19].
Furthermore, two glycoproteins: lactoferrin (Lf), an
abundant iron-binding compound, and free secretory
component (fSC), an 80-kDa compound found in exter-
nal fluids, were shown to be involved in the inhibition of
adherence of ETEC [18].
Preliminary studies carried out in our laboratory indicat-
ed that the non-immmunoglobulin fraction of human
milk was able to inhibit the adhesion of EPEC strains to
HeLa cells. Therefore, to investigate the inhibitory activ-
ity of human milk components, especially fSC and Lf, we
fractionated milk proteins using a method developed to
purify fSC, which also allowed isolation of Lf. All frac-
tions obtained during the process were analysed to deter-
mine protein content and concentration, and ability to
inhibit EPEC adhesion.
Results
Effect of defatted milk, casein fraction and whey
The protein concentrations of defatted milk, casein frac-
tion and concentrated whey proteins were respectively
12.0 mg/ml, 2.75 mg/ml and 9.24 mg/ml. These samples
were diluted approximately 10 times for use in the inhi-
bition assay, as cytotoxic effects on HeLa cells were in-
duced at higher concentrations or with prolonged
incubation of the milk protein fractions. Even at these di-
luted concentrations, defatted milk and whey were able
to significantly inhibit the adhesion of EPEC by 20% and
17% respectively. No changes in adhesion pattern were
observed in the presence of milk and in most cases the
inhibitory effect was easily recognised by mere observa-
tion.
SDS-PAGE protein separation of defatted milk (data not
shown) and concentrated whey proteins (Fig. 1, lane 2)
showed an identical and typical profile of proteins de-
scribed for human milk [25]. The bands of ~56.3 and
26.5 kDa represented heavy and light chains of immu-
noglobulins. The band of ~78 kDa represented lactofer-
rin and secretory component, as their molecular weights
are very similar. Serum albumin and α -lactalbumin were
represented by the bands of ~63.2 and 13.0 kDa; while
caseins varied from 28.3 to 31.7 kDa [25].
Electrophoretic analyses of the whey protein revealed
that the whey preparation, even after acid precipitation,
contained residual casein. Thus, in order to better under-
stand the ability of whey protein to inhibit EPEC adhe-
sion, purified casein and κ  casein commercially acquired
(Sigma-Aldrich Corp.) were assayed at 300 µg/ml. Nei-
ther of the caseins inhibited EPEC adhesion.
Effects of the fractions obtained by chromatography
Every protein peak eluted from the chromatographic
procedure was assayed to determine its inhibitory activ-
ity on EPEC adhesion. The chromatographic profile of
human whey proteins eluted from the Sephacryl S200
column is shown in Fig 2. At 320 µg/ml of protein, the
immunoglobulin fraction (P1-S) eluted from the gel fil-
tration inhibited adhesion of EPEC by 12%. SDS-page
analyses of the immunoglobulin fraction presented a
Figure 1
Coomassie blue-stained SDS-PAGE of the milk fractions.
Lane 1, molecular mass markers (66, 45, 36, 29, 24, 20.1, and
14.2 kDa); lane 2, concentrated whey; lane 3, pooled frac-
tions from the first peak of the Sephacryl S-200 (P1-S) col-
umn; lane 4, pooled fractions from the second peak of the
Sephacryl S-200 (P2-S) column; lane 5, pooled fractions from
the third peak of the Sephacryl S-200 (P3-S) column; lane 6,
active pooled proteins separated by DEAE cellulose (fSC and
Lf); lane 7, pooled protein not retained by Heparin-Sepha-
rose (fSC); lane 8, pooled fractions eluted from Heparin-
Sepharose with approximately 0.7 M NaCl (Lf).BMC Microbiology 2001, 1:25 http://www.biomedcentral.com/1471-2180/1/25
typical profile of sIgA, showing three main protein bands
corresponding to the SC, heavy chain, and light chain,
with estimated molecular weights of 78 kDa, 57 kDa, and
26 kDa respectively (Fig. 1, lane 3). It also contained
bands ranging from ~28 to ~30 kDa that may corre-
spond to casein which has remained after the precipita-
tion. As purified casein did not inhibit bacterial
adherence, it was assumed that sIgA was responsible for
the observed inhibitory effect.
Inhibitory activity of 8% was found in the non-immu-
noglobulin P2-S fraction at 225 µg/ml, where Lf and fSC
were present (Fig. 1, lane 4). Concentrated P2-S was ap-
plied to DEAE cellulose and the active fraction, contain-
ing both Lf and fSC, was recovered. This fraction showed
one main protein band of approximately 79 kDa (Fig. 1,
lane 6), which at 100 µg/ml, significantly inhibited EPEC
adhesion to HeLa cells by 14%.
Because the most prevalent contaminant in the purifica-
tion of fSC is lactoferrin, [20] which has a molecular
weight of about 80 kDa, the active material recovered
from the ion exchange chromatography was applied to
Heparin-Sepharose to separate fSC from Lf. Under this
procedure, fSC and Lf were separated into two peaks.
Thus isolated fSC and Lf significantly inhibited the adhe-
sion of EPEC to HeLa cells at 105 µg/ml and 157 µg/ml,
respectively. fSC showed a very strong inhibition (32%)
while Lf exhibited a weak (4.5%), but still significant in-
hibition.
As it has been shown that Lf may affect bacterial growth
[12], growth of the E. coli strain was measured during ex-
posure to the peak containing Lf under the same condi-
tions as used in the inhibition assay. The CFU were
determined and compared with the CFU obtained in the
absence of Lf. No inhibition of bacterial growth was ob-
served. Similarly, no growth inhibition was detected
when same procedure was carried out using purified fSC.
Electrophoretic analyses of the first peak eluted from the
affinity chromatography showed the presence of a major
protein band of 79 kDa, corresponding to fSC (Fig. 1, lane
7), and also the two bands of ~28 kDa and 31 kDa that
may correspond to casein. Similarly, the second peak
presented a band of 79 kDa corresponding to lactoferrin
(Fig. 1, lane 8). To confirm the identity of Lf and fSC, im-
munoblotting assays were performed. Using anti-Lf, the
main band of ~79 kDa corresponding to Lf (Fig. 3a, lane
2) and commercial lactoferrin (Fig. 3a, lane 3) were re-
vealed. No Lf was present in the peak that contained fSC
(Fig. 3a, lane 1). In the blot from the peak containing fSC,
anti-fSC recognised the band of ~79 kDa (Fig. 3b). These
results showed that both purified fSC and Lf were able to
inhibit the adhesion of EPEC.
During the chromatographic procedure, α  lactoalbumin
was also purified (Fig. 1, lane 5) and identified using a
corresponding antibody (Fig. 3c), but when assayed at
300 µg/ml, α  lactoalbumin was not able to inhibit adhe-
sion.
Commercial lactoferrin and α  lactoalbumin
Commercially available lactoferrin and α  lactoalbu-
min(Sigma-Aldrich Corp.) from human milk at 300 µg/
ml in 0.05 M Tris-HCl pH 7.6 containing 0.05 M NaCl,
were also assayed to confirm their effect on the adhesion
of EPEC. Commercial lactoferrin inhibited adhesion by
24%, while the commercial α  lactoalbumin showed no
activity. These results support our findings that purified
preparations of Lf have inhibitory activity and that α  lac-
toalbumin does not.
Discussion
This study demonstrated that the immunoglobulin frac-
tion, the free secretory component and lactoferrin of hu-
man milk inhibit adhesion to HeLa cells by EPEC strains.
Several studies have shown an important role of im-
mmunoglobulins, mainly sIgA, in the protective effect of
human milk against diarrhoea [9–11,18,19,26]. The lo-
calized adhesion of EPEC to cultured epithelial cells has
Figure 2
Chromatography of concentrated whey proteins on
Sephacryl S-200 HR column (2.6 cm ×  80.0 cm). Peaks were
monitored at 280 nm and eluted with 0.1 M Tris-HCl, pH
7.6, supplemented with 0.5 M NaCl, 1 mM phenylmeth-
anesulphonyl fluoride, 0.1% NaN3 and 50 mM ε -amino n-cap-
roic acid, pH 7.6; the flow rate was 120 ml/h and fractions of
5 ml were collected. The horizontal lines under the respec-
tive peaks indicate pooled fractions. P1-S, P2-S and P3-3
denote the pooled peaks.BMC Microbiology 2001, 1:25 http://www.biomedcentral.com/1471-2180/1/25
been shown to be inhibited by the immunoglobulins of
human milk [9,26]. As we verified that the immunoglob-
ulin fraction inhibited EPEC adherence to HeLa cells, the
present work supports previous findings.
In recent studies, we have shown that the non-immu-
noglobulin fraction of human milk inhibits the adher-
ence of ETEC, DAEC, and EAEC [18,19]. Furthermore,
two glycoproteins, lactoferrin and free secretory compo-
nent, were shown to be involved in the inhibition of
ETEC adherence [18]. In the present work, we have
shown that the same two glycoproteins, at lower concen-
tration than found in human milk, inhibited the adhe-
sion of EPEC. These results indicate that these
compounds may present a broad range of inhibition, act-
ing on different categories of diarrhoeagenic E. coli.
Lf is considered to be an important non-specific defence
factor against gastrointestinal infections, causing iron-
deprivation of microorganisms by its iron-scavenging
ability [12,13,27,28]. More recently, specific Lf binding
receptors have been described in several bacterial patho-
gens [29–32]. Studying the specific binding of Lf to E.
coli isolated from human intestinal infection, Naidu et al.
[33] showed that some serotypes of EPEC and ETEC
strains bound significantly more Lf than other pathogen-
ic groups. As we found that Lf also inhibits EPEC adhe-
sion, it may be possible that Lf binds to bacterial
adhesion-associated compounds found in EPEC strains.
Similarly, it has been shown [16,17] that human colos-
trum contains IgA that recognises the adherence-associ-
ated proteins of EPEC.
There is little information about the role of fSC in secre-
tions, but some studies suggest that it may have a protec-
tive role against diarrhoea [34,35]. In this work we
showed that fSC inhibited the adherence of EPEC strains
in vitro, indicating that this compound may be an impor-
tant non-specific defence factor because it is also found
in intestinal secretions [36] and may provide protection
for the mucous membranes which are the initial target in
most infections.
Previous studies [9] have established the association be-
tween the presence of fucosylated oligosaccharides in
human milk and inhibition of adhesion of EPEC strains
to Hep-2 cells. As the sugar moieties of fSC and Lf are
similar and rich in fucosylated oligosaccharides residues
[37,38], there might be a connection between our find-
ings and the previous studies. Some of the oligosaccha-
rides found to inhibit bacterial adherence might even be
the degradation products of the glycosylated compo-
nents of milk, as it is known that human milk contains
specific hydrolytic enzymes and fSC is very sensitive to
proteolysis [20,39]
Several studies have suggested a role of human milk gly-
coconjugates acting as cell surface homologues to inhibit
pathogen binding to host cell receptors [40]. Therefore,
by inhibiting the adhesion of EPEC, the glycoproteins Lf
and fSC may be functioning as receptor analogues. On
the other hand, the work of Vanmaele et al. [41] indicates
that glycoconjugates containing fucosylated residues
cause a decrease in the expression of the adherence-re-
lated proteins of EPEC, such as BFP and intimin. As Lf
and fSC are rich in fucosylated oligosaccharides, they
may be involved in such an activity.
Conclusions
This study demonstrated that the immunoglobulin frac-
tion, the free secretory component and lactoferrin of hu-
man milk inhibit EPEC adhesion to HeLa cells. Despite
our lack of understanding of the specific mechanism by
which Lf and fSC inhibit the adhesion of EPEC to epithe-
lial cells, our results indicate the potential of these com-
pounds to prevent EPEC-mediated infant diarrhoea or to
act as therapeutic agents for treating EPEC infection.
Materials and methods
Bacterial strain and breast milk samples
The EPEC strain, 0311-1 (O11 1ab:H2, eae+, bfp+ e
EAF+) isolated from a child with diarrhoea in São Paulo,
Brazil, was kindly provided by Dr. B.C. Guth (UNIFESP,
Figure 3
SDS-PAGE and immunoblotting of purified whey proteins. A:
lanes 1, 2 and 3 correspond, respectively, to the pooled pro-
tein not retained by Heparin-Sepharose (fSC), the pooled
fractions eluted from Heparin-Sepharose with approximately
0.7 M NaCl (Lf) and commercial lactoferrin stained with
coomassie blue; lanes 4, 5 and 6 correspond to the same
samples revealed by their reaction with Lf antibodies. B:
pooled fractions not retained by Heparin-Sepharose (fSC)
stained with coomasie blue (lane 1) and immunostained by
reaction with SC antibodies (lane 2).C: P3-S stained with
coomasie blue (lane 1) and immunostained by reaction with a
lactoalbumin antibodies (lane 2).BMC Microbiology 2001, 1:25 http://www.biomedcentral.com/1471-2180/1/25
Brazil). The bacterial strain was grown overnight in
Trypticase Soy Broth at 37°C and 100 µl of this culture
was inoculated in 5 ml of the same medium. Bacterial
growth was monitored by spectrophotometry at 540 nm,
and cultures were used in the assay when they reached
0.6 (exponential phase).
Human milk samples were obtained from the Human
Milk Bank of the Hospital Materno Infantil (Brasilia,
Brazil). Aliquots of individual frozen samples were taken
from at least 10 lactating mothers up to two months after
delivery, and pooled.
Fractionation of human milk
Fractionation was performed following the method de-
scribed by Mestecky et al. [20] to purify fSC, as previous-
ly modified [18]. Briefly, defatted milk, casein and
concentrated whey were obtained respectively by centrif-
ugation, acetic acid precipitation and ammonium sul-
phate precipitation. Concentrated whey was fractionated
on a Sephacryl S-200 HR column (2.6 cm ×  80 cm) equil-
ibrated with 0.1 M Tris-HCl, pH 7.6, supplemented with
0.5 M NaCl, 1 mM phenylmethanesulphonyl fluoride,
0.1% NaN3 and 50 mM ε -amino n-caproic acid. Fractions
from peaks thus obtained were pooled, and proteins
were precipitated with ammonium sulphate to 70% sat-
uration. Concentrated proteins obtained from the sec-
ond peak of the Sephacryl S200 HR column were
dialyzed against 0.01 M Tris-HCl pH 7.6 containing 0.05
M NaCl, and applied to a DEAE cellulose column equili-
brated with the same buffer. For further purification, the
eluted material from the DEAE column was again con-
centrated by adding ammonium sulphate to 70% satura-
tion, dialyzed against 0.05 M Tris-HCl pH 8.0 containing
0.2 M NaCl and applied to a Heparin Sepharose affinity
column equilibrated with the same buffer.
The protein content of the concentrated fractions was
measured by the method of Bradford [21] and monitored
by SDS-PAGE on acrylamide (10%) gels using the meth-
od of Laemmli. [22].
Bacterial adherence assay
Adhesion tests were carried out as described previously
[5] with some modifications. HeLa cells (1.6 ×  105 cells
ml-1, 600 µl) were grown for 48 h at 37°C in 199 medium
with 10% foetal bovine serum in 24-well tissue culture
plates containing a cover slip. The medium was replaced
with 300 µl of 199 medium supplemented with 2% foetal
bovine serum and 1% D-mannose to inhibit the eventual
adhesion mediated by adhesins that bind to mannosidic
receptors, 100 µl of a sample of milk, and 75 µl of an ex-
ponential phase bacterial culture. After 30 minutes at
37°C, wells were washed with phosphate-buffered saline
six times, and 500 µl of 199 medium with 2% foetal bo-
vine serum was added to each well. Plates were incubat-
ed for 3 hours at 37°C. Cells were then washed three
times with phosphate-buffered saline, fixed with metha-
nol and stained with May-Grünwald and Giemsa as de-
scribed previously [5]. Tests were carried out in triplicate
on three different occasions, and 250 or more HeLa cells
were observed in each preparation. The effect of defatted
milk, whey proteins, and immunoglobulin and non-im-
munoglobulin fractions on bacterial adherence was de-
termined by calculating the percentage of cells with
microcolonies (formed by at least five attached bacteria)
in relation to the control, carried out under identical con-
ditions, but in the absence of a milk sample.
Immunoblotting
Western blot procedures including SDS-PAGE and elec-
trotransfer to nitrocellulose membrane were carried out
as described by Laemmli and Towbin et al. [22,23].
Membranes were blocked with 0.2 % tween 20 in PBS for
18 hours at 10°C and then incubated overnight with com-
mercially acquired antibodies (rabbit antibody to human
lactoferrin, goat antibody to human SC, rabbit antibody
to human ∝  lactoalbumin – Sigma-Aldrich Corp.). After
three washes with PBS, membranes were immunos-
tained using peroxidase-conjugated anti-rabbit IgG or
peroxidase-conjugated anti-goat IgG (Sigma-Aldrich
Corp.) and developed using the ECL detection system
(Amersham Pharmacia Biotech).
Statistical analysis
Differences in percentage of bacterial adhesion were
compared statistically by the z test of proportions [24].
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